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Detection of SARS Coronavirus in Plasma by Real-Time RT-PCR
to the editor: The identification and sequencing
of a novel coronavirus1 associated with the recently
described severe acute respiratory syndrome (SARS)2
have permitted the development of antibody-based
and genome-based tests for the infection.3,4 Al-
though antibody seroconversion provides reliable
proof of infection, it is not suitable for early diagno-
sis. Techniques for genome detection have the po-
tential to provide earlier diagnosis, but the sensitiv-
ity of genome-based tests of respiratory samples
such as nasal and throat swabs is likely to be low in
patients presenting early with fever alone, before
the development of respiratory symptoms. We there-
fore investigated the potential of genome detection
in blood to provide a diagnosis during this very early
phase.
A total of 65 plasma samples obtained within 10
days after the onset of fever were available from 26
patients with SARS at the Prince of Wales Hospital,
Hong Kong. All patients met the World Health Or-
ganization’s case definition and had seroconver-
sion or a fourfold increase in antibody to the SARS-
associated coronavirus (SARS-CoV), as measured by
immunofluorescence. Viral RNA was extracted and
amplified by means of a nested reverse-transcrip-
tase polymerase chain reaction (RT-PCR), with the
use of both qualitative and quantitative real-time
assays (ABI Prism 7000 system) and the primer sets
described by Drosten et al.4 Full details of the assay
protocols are available as Supplementary Appendix
1 with the full text of this letter at www.nejm.org.
The rate of detection of SARS-CoV RNA in the
24 patients tested within three days after the onset
of fever was 79 percent (detection in 19 of the 24
patients). Between 3 and 10 days after the onset of
fever, no additional patients with viremia were iden-
tified with the use of either the qualitative or the
quantitative assay (Fig. 1A). In the 19 patients in
whom the viral genome could be quantified on one
or more occasions, the plasma viremia level rose
early and was maximal at around day 4 or 5 after the
onset of fever (Fig. 1B). The viral load then decreased
in most patients, though it remained detectable at
a low level in four of the five patients from whom
samples were obtained on either day 9 or day 10.
The detection sensitivity of 79 percent within the
first three days is better than the reported rate for
nasal and throat swabs and is equivalent to that for
nasopharyngeal aspirates.3 With the current proto-
col, RNA from only 70 µl of plasma was analyzed,
and it is likely that centrifugation of a larger volume
of plasma would increase the detection sensitivity.
The use of plasma viremia for diagnosing SARS-CoV
infection also has the advantage of not requiring
nasopharyngeal aspiration, which is regarded as a
risk-prone procedure.5
Paul R. Grant, Ph.D.
Jeremy A. Garson, M.D., Ph.D.
Richard S. Tedder, F.R.C.P., F.R.C.Path.
Royal Free and University College Medical School
London W1T 4JF, United Kingdom
paul.grant@ucl.ac.uk
Figure 1. Detection of Severe Acute Respiratory Syndrome (SARS)–Associated 
Coronavirus with a Reverse-Transcriptase Polymerase-Chain-Reaction (PCR) 
Assay (Panel A) and Changes in the Viral Load (Panel B) in Plasma Samples 
Obtained up to 10 Days after the Onset of Fever in 26 Patients.
Viral infection was considered to have been detected if viral RNA was found 
by either the nested conventional or real-time PCR method. The number at 
each time point in Panel B is the number of samples tested.
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Estimated Timing of the Last Common Ancestor 
of the SARS Coronavirus
to the editor: Using the viral sequences derived
from clinical specimens collected in Hong Kong
between February and April 2003 from 139 patients
with the severe acute respiratory syndrome (SARS),1
we attempted to estimate the timing of the last com-
mon ancestor of the coronavirus associated with
the recent outbreaks of SARS. We previously report-
ed the results of phylogenetic analysis, using the
same set of spike-gene sequences as that in the
SARS-associated coronavirus (SARS-CoV) isolated
during the early phase of the outbreak (February to
April) in Hong Kong and southern China, together
with those available in the public data base.1
Assuming that the mutation rate was uniform,
we carried out a linear regression analysis that was
similar to the approach used for the timing of the
origin of human immunodeficiency virus type 1.2
The divergence (i.e., branch length), based on the
genetic distance between the isolates and the root
of the phylogram, was plotted as a function of the
sampling time (Fig. 1).2,4 The root was defined as
the first diverging point2 of the hypothetical com-
mon ancestor of SARS-CoV. The best-fit line was
generated by the linear regression analysis extrap-
olated back to the past. The divergence of the se-
quences from the common ancestor was found to
have a linear relation with time (P<0.001), in a pro-
gressive manner. The last appearance of the com-
mon ancestor of SARS-CoV was estimated to be on
December 12, 2002 (95 percent confidence inter-
val, September 26, 2002, to January 13, 2003), when
the value of the divergence was zero. This finding
suggests that the first deviation of the ancestral vi-
rus may have occurred in late 2002, close to the time
of the first reports of SARS in southern China.5
Although additional sampling of sequences, in-
volving a longer time frame, is needed, the current
findings shed some light on the origin of SARS-CoV
and thus may help elucidate its evolution.
Figure 1. Timing of the Most Recent Common Ancestor of the Hong Kong 
SARS-CoV.
The divergence of the sequence from the ancestral sequence was plotted 
against sampling time (GraphPad Prism, version 4.00).3 The red line repre-
sents the best-fit line obtained by linear regression analysis, and the blue lines 
indicate the 95 percent confidence intervals.
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